Bosnian international university active in EU diagnostics research and academic institutional reform, offering rare Western Balkans consortium presence.
Internacionalni Univerzitet u Sarajevu (IUS) is a private international university in Sarajevo, Bosnia and Herzegovina, that participates in EU-funded research as a consortium partner. Their H2020 portfolio spans two distinct domains: structural reform in higher education institutions — including gender equality plan implementation and academic culture change — and molecular health diagnostics, specifically RNA-based biomarker development for COVID-19 prognosis and cardiovascular risk prediction. As one of the few Western Balkans institutions active in H2020, they provide both regional geographic reach and local academic networks in Southeast Europe to European consortia.
Participated in SAGE (2016-2019), a Coordination and Support Action focused on systemic gender equality plans, academic culture change, and key performance indicators for institutional transformation.
Participated in COVIRNA (2020-2023), an Innovation Action developing long non-coding RNA biomarkers as an in-vitro diagnostic test for COVID-19 prognosis and patient stratification.
COVIRNA project keywords include AI and prediction model alongside biomarker and patient stratification work, indicating involvement in computational approaches to diagnostics.
In their early H2020 phase (2016-2019), IUS focused entirely on organizational science — implementing gender equality frameworks, academic excellence benchmarks, and cultural change programs within higher education institutions, consistent with their role as a university reforming its own governance. By 2020-2023, their participation shifted to hard biomedical science: contributing to a diagnostics innovation project centered on long non-coding RNA as prognostic biomarkers for COVID-19 and cardiovascular complications. Whether this reflects a new research faculty coming online or opportunistic consortium inclusion during the pandemic period is unclear from two projects alone, but the keyword shift is dramatic.
Their trajectory points toward health science and AI-assisted diagnostics, but with only two projects in entirely different domains, this trend should be treated as provisional until further participation confirms a sustained focus.
IUS has participated exclusively as a consortium partner across both projects, never taking a coordinating role. Their 21 unique partners across 13 countries — from just two projects — indicates they join large, well-connected European consortia rather than building their own networks. This pattern is typical of institutions that contribute regional representation or a specific departmental capability, rather than driving project strategy or managing execution.
IUS has reached 21 unique consortium partners across 13 countries through only two projects, which reflects the size and geographic spread of the consortia they joined rather than their own networking. No repeated partner relationships are evident, suggesting broad but shallow network ties.
IUS is one of the very few Bosnian universities active in H2020, making them a rare entry point for European consortia that need Western Balkans geographic coverage — a requirement that appears with some regularity in Horizon Europe calls targeting inclusivity and regional spread. Beyond geography, their combination of academic governance reform experience and emerging molecular diagnostics work spans two application domains that rarely overlap, offering unusual flexibility for interdisciplinary consortia. For partners specifically needing a credible Southeast European academic institution, IUS fills a gap that no other Bosnian HES currently covers at scale in EU research.
